Search Results 351-360 of 18887 for B cell lymphomas

  1. Hodgkin lymphoma (Hodgkin disease) - Stages - Mayo Clinic

    The letter B means that you have some symptoms, such as drenching night sweats, fever or weight loss. Hodgkin lymphoma prognosis. The cancer prognosis tells you ...

  2. Lymphoma - Survival rates - Mayo Clinic

    Survival rates for lymphoma are different for each type of lymphoma. They ... B-cell lymphoma. Journal of Hematopathology. 2019; doi:10.1007/s12308-019 ...

  3. Clinical trials - Oncology (Medical)

    Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...

  4. Transplant Medicine Clinical Trials - Medical Professionals

    To investigate the efficacy of autologous Epstein-barr virus (EBV)-specific T cells for the treatment of EBV positive Diffuse Large B Cell Lymphoma (DLBCL), ...

  5. Lymphoma Group - Overview - Mayo Clinic

    The Lymphoma Group at Mayo Clinic evaluates and treats patients with ... Cutaneous T-cell lymphoma; Castleman disease. Request an appointment. Aug. 30 ...

  6. Lymphoma survival rates - Mayo Clinic

    Incorporation of digital gene expression profiling for cell-of-origin determination (Lymph2Cx Testing) into the routine work-up of diffuse large B-cell lymphoma ...

  7. Clinical trials - Oncology (Medical)

    ... B-cell lymphoma 2 (BCL2) inhibitor. MC1733, Phase I Trial of Intratumoral Administration of a Measles Virus Derivative Expressing the Helicobacter pylori ...

  8. Types of prostate cancer: Common and rare forms - Mayo Clinic

    Most prostate lymphomas are types of non-Hodgkin lymphoma, such as diffuse large B-cell lymphoma and other B-cell lymphomas. Other cancers can affect the ...

  9. Paul J. Hampel, M.D. - Doctors and Medical Staff - Mayo Clinic

    ... lymphoma, hairy cell leukemia, and T-cell prolymphocytic leukemia. Dr ... B-cell lymphoma · Burkitt lymphoma · Chronic lymphocytic leukemia · Follicular ...

  10. A Study Evaluating The Safety, Efficacy, And Pharmacokinetics Of Mosunetuzumab And A Combined Regimen Of Mosunetuzumab And Venetoclax In Participants With Relapsed Or Refractory Chronic Lymphocytic Leukemia - Mayo Clinic

    ... B-cell lymphoma 2 (BCL2) inhibitor. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...